Accretive

Accretive functions as a permanent-capital company builder, not a traditional private equity fund. It does not raise blind-pool funds from limited partners, does not operate under a fixed fund life, and invests its own capital. This structure allows indefinite hold periods and removes the liquidity pressure that shapes typical PE portfolio behavior.

The firm does not source existing companies for acquisition. It identifies an industry domain, develops a proprietary thesis about an unmet customer need, designs a business model to capture the value gap, and then recruits an executive team to build the company. Deal flow is entirely internal and thesis-driven, not auction-based or intermediary-dependent.

Accretive builds companies from the ground up — effectively seed and early-stage creation — across industries undergoing structural change. Its portfolio spans digital health and healthcare services (R1, Accolade, Accumen), online marketplaces and insurtech (Fandango, Insureon), education (Everspring), and enterprise services (Exult, Xchanging). The firm targets industries where a new offering can create a step-change in customer value.

The firm does not publish a formal exclusions list. Its historical pattern shows no activity in hard-asset infrastructure, natural resources, real estate development, or consumer-packaged goods. The model gravitates toward technology-enabled services, information-intensive industries, and domains where procurement or administrative complexity creates a large addressable market for an outsourced solution.